Loss-of-function JAK1 frameshift mutations are enriched in endometrial and stomach MMRd tumors, are associated with downregulation of the IFN response, lower infiltration of immune cells, limited anti-tumor immunity, and reduced response to ICB (31, 32, 244, 256, 257) (Figure 4). The gene discussed is IFNA1; the disease is neoplasm.